AbbVie Inc. (ABBV) vs The Coca-Cola Company (KO)
A side-by-side comparison of AbbVie Inc. and The Coca-Cola Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; KO is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
KO
The Coca-Cola Company
$88.27Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs KO
growth of $100 · dividends reinvested · last 14yABBV +1164.7%KO +241.7%ABBV compounded faster
ABBV KO
ABBV vs KO: by the numbers
- •ABBV is the larger company ($465.51B vs $379.78B market cap).
- •KO trades at the lower trailing earnings multiple (26.44 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •KO converts more revenue to profit (27.80% vs 5.79% net margin).
- •KO grew revenue faster over the past five years (8.07% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 2.47%).
Metrics side by side
Valuation
| Metric | ABBV | KO |
|---|---|---|
| P/E ratio | 125.98 | 26.44 |
| Forward P/E | N/A | 25.72 |
| P/S ratio | 7.26 | 7.36 |
| P/B ratio | 16.57 | 10.78 |
| PEG ratio | N/A | 0.98 |
| EV / EBITDA | 20.46 | 25.53 |
| FCF yield | 4.58% | 3.46% |
Profitability
| Metric | ABBV | KO |
|---|---|---|
| Gross margin | 70.68% | 61.74% |
| Operating margin | 27.60% | 29.34% |
| Net margin | 5.79% | 27.80% |
| ROE | 13.23% | 40.74% |
| ROIC | 12.97% | 13.00% |
Dividends
| Metric | ABBV | KO |
|---|---|---|
| Dividend yield | 2.62% | 2.47% |
| Payout ratio | 284.39% | 68.20% |
Growth (annualized)
| Metric | ABBV | KO |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 8.07% |
| EPS CAGR (5Y) | -2.79% | 11.12% |
| FCF CAGR (5Y) | 3.24% | -9.38% |
| Total return CAGR (5Y) | 21.24% | 11.23% |
Frequently asked
- Which has the lower trailing P/E, ABBV or KO?
- KO has the lower trailing P/E: ABBV trades at 125.98 and KO at 26.44. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or KO?
- Over the past five years, KO grew revenue faster — ABBV at a 4.59% CAGR versus KO at 8.07%.
- Does ABBV or KO pay a bigger dividend?
- ABBV yields 2.62% and KO yields 2.47% based on trailing dividends and the latest price.
- Is ABBV or KO more profitable?
- KO runs the higher net margin — ABBV at 5.79% versus KO at 27.80%.
- How have ABBV and KO total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and KO delivered 10.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioCoca-Cola P/E ratioAbbVie dividend yieldCoca-Cola dividend yieldAbbVie ROECoca-Cola ROEAbbVie operating marginCoca-Cola operating marginAbbVie revenue growthCoca-Cola revenue growthAbbVie free cash flowCoca-Cola free cash flow
AbbVie & Coca-Cola appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.